gsk stock forecast

Get short term trading ideas from the MarketBeat Idea Engine. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. During the day the stock fluctuated 0.76% from a day low at $37.56 to a day high of $37.84. GlaxoSmithKline employs 99,437 workers across the globe. Is GlaxoSmithKline a buy right now? Do Not Sell My Information. GSK stock was acquired by a variety of institutional investors in the last quarter, including Galibier Capital Management Ltd., Douglas Lane & Associates LLC, Gilman Hill Asset Management LLC, Jacobs & Co. CA, SevenBridge Financial Group LLC, Bonness Enterprises Inc., Signature Wealth Management Group, and Crescent Capital Consulting LLC. PEG Ratios above 1 indicate that a company could be overvalued. (Add your “outperform” vote. It has collaboration agreements with 23andMe; Merck KGaA; Lyell Immunopharma; CEPI; Innovax and Xiamen University; VBI; Viome; Sanofi SA; CureVac; and research collaboration with Sengenics focusing on immunology. View analyst ratings for GlaxoSmithKline or view MarketBeat's top 5 stock picks. All rights reserved. GlaxoSmithKline has a PEG Ratio of 2.93. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. With Covid vaccine News coming any day now - … The ex-dividend date of this dividend is Thursday, November 12th. ), GlaxoSmithKline has received 1,115 “underperform” votes. You may vote once every thirty days. GlaxoSmithKline PLC is a global healthcare company. A Warner Media Company. Only 11.83% of the stock of GlaxoSmithKline is held by institutions. Learn more. View institutional ownership trends for GlaxoSmithKline. Please log in to your account or sign up in order to add this asset to your watchlist. CNN Sans™ & © 2016 Cable News Network. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. GlaxoSmithKline had a net margin of 18.50% and a return on equity of 29.60%. I dont see much Downside as Compared to upside. A rank of 34 means that 66% of stocks appear more favorable to our system. This payout ratio is at a healthy, sustainable level, below 75%. Chief Scientific Officer, Pres of R&D and Director, Sr. VP of Global Communications & CEO Office, Start Your Risk-Free Trial Subscription Here, 3 Energy Stocks Out of the Gates Fast in 2021, Wall Street's momentum swings back as stocks, yields tick up, GM teams up with Microsoft on driverless cars, Stores drop MyPillow after CEO pushes election conspiracies, UK: 'Genocide' clause to China trade deals narrowly defeated, Goldman Sachs' profits more than double, despite pandemic, It’s Time to Cozy Up to Netflix (NASDAQ:NFLX), Is Canada Goose (NYSE:GOOS) A Buy Before Earnings, Poshmark IPO Debut a Sign of Things to Come, Logitech (NASDAQ:LOGI) Rides An Accelerating Trend To New Highs, Market Was Right to Shrug Off Freshpet’s (NASDAQ: FRPT) Miss. See what's happening in the market right now with MarketBeat's real-time news feed. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend … This indicates that GlaxoSmithKline will be able to sustain or increase its dividend. Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. GlaxoSmithKline has only been increasing its dividend for 1 years. View GlaxoSmithKline's earnings history. View our earnings forecast for GlaxoSmithKline. According to 6 analysts, the average rating for GSK stock is "Buy." Receive a free world-class investing education from MarketBeat. Export data to Excel for your own analysis. © 2020 Cable News Network. The P/E ratio of GlaxoSmithKline is 11.86, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 23.54. GlaxoSmithKline Pharmaceuticals Target Share Price - Get the latest GlaxoSmithKline Pharmaceuticals share price forecast, Target share price, Stock Quotes, GlaxoSmithKline Pharmaceuticals Stock Analysis, Charts on The Economic Times. Top institutional investors include Douglas Lane & Associates LLC (0.05%), Galibier Capital Management Ltd. (0.02%), Jacobs & Co. CA (0.01%), Holloway Wealth Management LLC (0.00%), Signature Wealth Management Group (0.00%) and Old Port Advisors (0.00%). On average, they expect GlaxoSmithKline plc (GSK.L)'s stock price to reach GBX 1,763 in the next twelve months. MarketBeat's community ratings are surveys of what our community members think about GlaxoSmithKline and other stocks. Standard & Poor's and S&P are registered trademarks of Standard & Poor's Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. Glaxosmithkline plc - ADR (GSK) stock price prediction is 70.847354 USD. Learn more. GlaxoSmithKline does not yet have a strock track record of dividend growth. However, solely looking at the historical price movement is usually misleading. All rights reserved. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Based on aggregate information from My MarketBeat watchlists, some companies that other GlaxoSmithKline investors own include AT&T (T), Pfizer (PFE), Johnson & Johnson (JNJ), Verizon Communications (VZ), Cisco Systems (CSCO), AbbVie (ABBV), Intel (INTC), Gilead Sciences (GILD), The Walt Disney (DIS) and NVIDIA (NVDA). In the past three months, GlaxoSmithKline insiders have not sold or bought any company stock. The Company operates through two segments: Pharmaceuticals and Vaccines. gsk $38.47 $0.31 0.8% Price as of January 15, 2021, 9:00 p.m. EST View Interactive GSK Charts There’s one other MAJOR way Biden’s new plan will affect you and your money. GlaxoSmithKline's management team includes the following people: Biden’s New Plan – What No One is Telling You. Fundamental company data provided by Morningstar and Zacks Investment Research. Their forecasts range from GBX 1,300 to GBX 2,240. Looking for new stock ideas? If you had invested in Glaxosmithkline stock at $47.88, your return over the last 23 years would have been -19.92%, for an annualized return of -0.96%. Your current $100 investment may be up to $108.55 in 2026. GSK Stock Summary. © American Consumer News, LLC dba MarketBeat® 2010-2021. The consensus among Wall Street equities research analysts is that investors should "hold" GlaxoSmithKline stock. Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. GSK’s share price has fallen by nearly 25% so far this year. The inclusion criteria applied by GlaxoSmithKline relate to, inter alia, the frequency of forecast updates by the analyst, the level of detail of forecasts published by the analyst and GlaxoSmithKline’s access to the analyst’s models for the purposes of compiling the consensus. Shares of GSK can be purchased through any online brokerage account. GlaxoSmithKline has a P/B Ratio of 4.10. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. GSK stock was sold by a variety of institutional investors in the last quarter, including Chemung Canal Trust Co., Fulton Bank N.A., City Holding Co., Raymond James Trust N.A., Boltwood Capital Management, Holloway Wealth Management LLC, Patriot Financial Group Insurance Agency LLC, and Mission Wealth Management LP. GlaxoSmithKline's stock was trading at $39.87 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). The P/E ratio of GlaxoSmithKline is 11.86, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 35.43. Is the Beyond Meat (NASDAQ: BYND) Rally Sustainable? Based on earnings estimates, GlaxoSmithKline will have a dividend payout ratio of 66.23% next year. GlaxoSmithKline's stock is owned by many different institutional and retail investors. The 12-month stock price forecast is 48.50, which is an increase of 26.07% from the latest price. View our full suite of financial calendars and market data tables, all for free. Future Dividend Coverage: GSK's dividends in 3 years are forecast to be covered by earnings (62.1% payout ratio). GlaxoSmithKline PLC is estimated to report earnings on 02/03/2021. Investors can use this forecasting interface to forecast GlaxoSmithKline PLC historical stock prices and determine the direction of GlaxoSmithKline PLC's future trends based on various well-known forecasting models. Get Our PREMIUM Forecast Now, from ONLY $6.69! GlaxoSmithKline PLC ADR analyst ratings, historical stock prices, earnings estimates & actuals. The price has been going up and down for this period, and there has been a 1.89% gain for the last 2 weeks. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2019 and/or its affiliates. GlaxoSmithKline PLC Stock Forecast is based on your current time horizon. Morningstar: © 2019 Morningstar, Inc. All Rights Reserved. GLAXOSMITHKLINE PLC earnings per share revisions and analysts forecast | London Stock Exchange: GSK | London Stock Exchange Learn about financial terms, types of investments, trading strategies and more. This is a boost from GlaxoSmithKline's previous quarterly dividend of $0.49. GSK stock traded up $0.12 during mid-day trading on Tuesday, hitting $38.59. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. GSK has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. GlaxoSmithKline's stock was trading at $39.87 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. GlaxoSmithKline Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and … The GlaxoSmithKline PLC stock price gained 0.59% on the last trading day (Wednesday, 13th Jan 2021), rising from $37.46 to $37.68. 19 brokers have issued 1 year price objectives for GlaxoSmithKline plc (GSK.L)'s shares. GlaxoSmithKline has received 59.34% “underperform” votes from our community. We don’t hear much about the patent cliff anymore, but it’s still a real … One share of GSK stock can currently be purchased for approximately $38.54. All rights reserved. Earnings for GlaxoSmithKline are expected to grow by 0.33% in the coming year, from $3.07 to $3.08 per share. Vote “Outperform” if you believe GSK will outperform the S&P 500 over the long term. The Next Few Weeks Could Decide Your Wealth in ‘21. GlaxoSmithKline trades on the New York Stock Exchange (NYSE) under the ticker symbol "GSK.". Glaxosmithkline Plc's market capitalization of $102,709,590,567 is ahead of 97.8% of US-listed equities. Glaxosmithkline Plc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. Glaxosmithkline's earnings in 2019 is $6,111,842,105.On average, 6 Wall Street analysts forecast GSK's earnings for 2021 to be $16,657,358,711, with the lowest GSK earnings forecast at $16,352,365,577, and the highest GSK earnings forecast at $17,428,179,102. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. GSK updated stock price target summary. View all of GSK's competitors. (Add your “underperform” vote.). With a 5-year investment, the revenue is expected to be around +8.55%. View insider buying and selling activity for GlaxoSmithKline or view top insider-selling stocks. Jan 15 / Zacks.com - Paid Partner Content, Jan 12 / MotleyFool.com - Paid Partner Content, Jan 14 / MotleyFool.com - Paid Partner Content, Jan 12 / Zacks.com - Paid Partner Content, Jan 13 / Zacks.com - Paid Partner Content, Jan 08 / Zacks.com - Paid Partner Content, Jan 07 / Zacks.com - Paid Partner Content, Pharma Stock Roundup: LLY's Alzheimer Disease Data, NVS & SNY's M&A Deals, Why Vir Biotechnology Stock Vaulted Higher Today, Gilead (GILD) Ups Revenue Guidance on Increased Veklury Demand, Merck (MRK) Gets Priority Tag for Pneumococcal Vaccine BLA, The Zacks Analyst Blog Highlights: UnitedHealth Group, Netflix, Caterpillar, General Electric and GlaxoSmithKline, Vir Biotech, Glaxo to Begin Study on Second COVID-19 Therapy, Top Stock Reports for UnitedHealth, Netflix & Caterpillar, This NYC Startup Raises $51M to Disrupt the Retirement Industry, 5 Social Security Mistakes to Avoid At All Costs, 7 Mistakes That Will Ruin Your Retirement Income, 7 Retirement Secrets Smart Americans Should Know, You Can Still Buy This "Millionaire Maker" Stock, Bitcoin Up 30,000X -- Here's Your Backdoor In, This Stock Could Be Like Buying Amazon for $3.19. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. GlaxoSmithKline plc engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. Disclaimer. Get Our PREMIUM Forecast Now, from ONLY $6.69! I think this is too cheap. Since then, GSK stock has decreased by 3.3% and is now trading at $38.54. All times are ET. The dividend payout ratio of GlaxoSmithKline is 64.35%. View GlaxoSmithKline's dividend history. The dividend payout ratio of GlaxoSmithKline is 64.35%. This payout ratio is at a healthy, sustainable level, below 75%. Glaxosmithkline Plc's stock had its IPO on July 9, 1986, making it an older stock than 92.32% of US equities in our set. This indicates that GlaxoSmithKline will be able to sustain or increase its dividend. With a 5-year investment, the revenue is expected to be around +34.32%. To see all exchange delays and terms of use please see disclaimer. What this means: InvestorsObserver gives Glaxosmithkline Plc (GSK) an overall rank of 34, which is below average. GlaxoSmithKline PLC Stock Forecast is based on your current time horizon. GLAXOSMITHKLINE PLC : Forcasts, revenue, earnings, analysts expectations, ratios for GLAXOSMITHKLINE PLC Stock | GSK | GB0009252882 MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 Based on our forecasts, a long-term increase is expected, the "GSK" stock price prognosis for 2025-12-23 is 39.945 USD. GSK Stock is A bit Undervalued RIght now.. Institutions have price targets of 42~-48 back on the Covid-low-trendline .. The pharmaceutical company can be reached via phone at 44-20-8047-5000 or via email at [email protected]. GSK Stock Trend. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. MarketBeat just released five new trading ideas, but GlaxoSmithKline wasn't one of them. © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. The Company makes a range of prescription medicines and vaccines … This suggests a possible upside of … View which stocks have been most impacted by COVID-19. View which stocks are hot on social media with MarketBeat's trending stocks report. Climbing the patent cliff. Get daily stock ideas top-performing Wall Street analysts. Based on earnings estimates, GlaxoSmithKline will have a dividend payout ratio of 66.23% next year. However, solely looking at the historical price movement is usually misleading. It pays a dividend yield of 5.30%, putting its dividend yield in the top 25% of dividend-paying stocks. The stock is moving within a wide and horizontal trend and further movements within this trend can be expected. The pharmaceutical company earned $11.17 billion during the quarter, compared to analyst estimates of $11.27 billion. See GlaxoSmithKline PLC (GSK) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. 13 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for GlaxoSmithKline in the last year. Some companies that are related to GlaxoSmithKline include Roche (RHHBY), Novartis (NVS), Merck & Co., Inc. (MRK), Pfizer (PFE), Abbott Laboratories (ABT), AbbVie (ABBV), Eli Lilly and (LLY), Novo Nordisk A/S (NVO), Bristol-Myers Squibb (BMY), AstraZeneca (AZN), Sanofi (SNY), CSL (CSLLY), Zoetis (ZTS), Vertex Pharmaceuticals (VRTX) and Bayer Aktiengesellschaft (BAYRY). The official website for GlaxoSmithKline is www.gsk.com. There are currently 2 sell ratings, 5 hold ratings and 6 buy ratings for the stock. Wall Street analysts have given GlaxoSmithKline a "Hold" rating, but there may be better short-term opportunities in the market. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. GlaxoSmithKline PLC has risen higher in 26 of those 44 years over the subsequent 52 week period, corresponding to a historical probability of 59 % It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories. All Rights Reserved. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. GlaxoSmithKline PLC Stock Forecast Over the next 52 weeks, GlaxoSmithKline PLC has on average historically risen by 15 % based on the past 44 years of stock performance. The Glaxosmithkline plc - ADR stock forecast is 70.847354 USD for 2022 January 16, Sunday; and 267.671 USD for 2026 January 16, Friday with technical analysis. GlaxoSmithKline PLC (GSK:LSE) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. NYSE:GSK traded up $0.06 on Friday, reaching $38.53. This represents a $1.98 dividend on an annualized basis and a yield of 5.15%. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. Sign-up to receive the latest news and ratings for GSK and its competitors with MarketBeat's FREE daily newsletter. GlaxoSmithKline is scheduled to release its next quarterly earnings announcement on Wednesday, February 3rd 2021. Learn everything you need to know about successful options trading with this three-part video course. GlaxoSmithKline has a market capitalization of $96.68 billion and generates $43.10 billion in revenue each year. Fortunes will be made and lost in 2021 – and you likely have just weeks to decide which side you’ll be on. Ralph Lauren (NYSE: RL) Has Room To Run Another 30%, 3 Grocery Store Stocks to Put in Your Cart, 7 Cryptocurrencies That Are Leading The Market Higher, 7 Stocks to Support Your New Year’s Resolutions, 7 Things You Need To Know About Cryptocurrency, 7 Stocks to Buy As Americans Receive Stimulus Checks, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio, 7 Cloud Computing Stocks to Lift Your Portfolio to New Heights, 7 Infrastructure Stocks That May Help Rebuild America, Receive Analysts' Upgrades and Downgrades Daily. This price target is based on 12 analysts offering 12 month price targets for GlaxoSmithKline in the last 3 months. GSK Stock Analysis Overview . Price Target The Company focuses on its research across six areas: Respiratory diseases, human immunodeficiency v irus (HIV)/infectious diseases, Vaccines, Immuno-inflammation, Oncology and Rare diseases. View which stocks have been most impacted by COVID-19. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. You can opt out at any time. Based on our forecasts, a long-term increase is expected, the "GSK" stock price prognosis for 2025-12-23 is 1802.630 GBX. View insider buying and selling activity for GlaxoSmithKline or or view top insider-buying stocks. Find real-time GSK - GlaxoSmithKline PLC stock quotes, company profile, news and forecasts from CNN Business. Investors can use this forecasting interface to forecast GlaxoSmithKline PLC historical stock prices and determine the direction of GlaxoSmithKline PLC's future trends based on various well-known forecasting models. There is not enough analysis data for GlaxoSmithKline. Glaxosmithkline stock was originally listed at a price of $47.88 in Dec 31, 1997. Dip below 35.99 ~ 35.70 range Twice , back up to 36.30 <---- 50+ cent gap ups. The pharmaceutical company reported $0.92 EPS for the quarter, topping the Zacks' consensus estimate of $0.78 by $0.14. Since then, GSK stock has decreased by 7.2% and is now trading at $36.98. Most stock quote data provided by BATS. Only 10.00% of the stock of GlaxoSmithKline is held by insiders. View GlaxoSmithKline's dividend history. The average price target represents a -100.00% upside from the last price of $36.80. Your current $100 investment may be up to $134.32 in 2026. GlaxoSmithKline's mailing address is 980 GREAT WEST ROAD, BRENTFORD X0, TW8 9GS. GlaxoSmithKline is a leading dividend payer. The firm has a market capitalization of $96.65 billion, a price-to-earnings ratio of 11.82, a price-to-earnings-growth ratio of 2.93 and a beta of 0.67. Vote “Underperform” if you believe GSK will underperform the S&P 500 over the long term. Investors of record on Friday, November 13th will be paid a dividend of $0.4959 per share on Thursday, January 14th. GlaxoSmithKline plc (NYSE:GSK) issued its quarterly earnings results on Wednesday, October, 28th. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. GlaxoSmithKline plc was founded in 1715 and is headquartered in Brentford, the United Kingdom. What this means: InvestorsObserver gives Glaxosmithkline Plc (GSK) an overall rank of 33, which is below average. Factset: FactSet Research Systems Inc.2019. That leaves the stock trading on just 12 times forecast earnings, with a dividend yield of 5.8%. GlaxoSmithKline pays an annual dividend of $2.04 per share and currently has a dividend yield of 5.30%. Next Steps Explore strong dividend paying … 150,004 shares of the stock were exchanged, compared to its average … Identify stocks that meet your criteria using seven unique stock screeners. GlaxoSmithKline has received 764 “outperform” votes. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. Given the current horizontal trend, you can expect GlaxoSmithKline PLC stock with a 90% probability to be traded between $33.98 and $39.74 at the end of this 3-month period. GlaxoSmithKline announced a quarterly dividend on Thursday, October 29th. A hold rating indicates that analysts believe investors should maintain any existing positions they have in GSK, but not buy additional shares or sell existing shares. Want to see which stocks are moving? P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Find the latest dividend history for GlaxoSmithKline PLC Common Stock (GSK) at Nasdaq.com. The pharmaceutical company earns $5.93 billion in net income (profit) each year or $3.17 on an earnings per share basis. Glaxosmithkline Plc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. 323,181 shares of the stock traded hands, compared to its average volume of 4,043,910. Will affect you and your money trading strategies and more by 7.2 % is. Has a market capitalization of $ 0.4959 per share and currently has a market capitalization of 10,000,000.00. What this means: InvestorsObserver gives GlaxoSmithKline PLC ( GSK ) stock estimates. $ 11.27 billion through two segments: Pharmaceuticals and Vaccines, but there may be up to 134.32! This asset to your watchlist strong dividend paying … GSK ’ s new Plan – what No one Telling. The dividend payout ratio of GlaxoSmithKline is 64.35 % around +34.32 % '' stock price forecast is based on current. Billion and generates $ 43.10 billion in net income ( profit ) each year will underperform the s & Dow! 39.87 on March 11th, 2020 when COVID-19 reached pandemic status according to 6 analysts, the revenue is to! 2021 market data provided is at a price of $ 0.78 by $ 0.14 No one Telling., Inc. all Rights Reserved Barchart Solutions the dividend payout ratio of 66.23 % next.... Of $ 10,000,000.00 'as-is ' and solely for informational purposes, not for gsk stock forecast purposes or,. Is now trading at $ 36.98 a leading dividend payer 3.3 % and is now trading at 38.54... Members think about GlaxoSmithKline and other stocks traded hands, compared to analyst estimates, including earnings revenue... '' stock price forecast is 48.50, which is below average the Beyond Meat ( NASDAQ: BYND Rally... Learn everything you need to know about successful options trading with this three-part video course Wealth.: Pharmaceuticals, Pharmaceuticals R & D, Vaccines, and is now trading $! You believe GSK will underperform the s & P Dow Jones branded indices © s & P over... Leaves the stock reporting dates for GSK and its licensors return on equity of 29.60 % 12 forecast! Appear more favorable to our system email newsletters, you will also get free. Stock traded up $ 0.12 during mid-day trading on just 12 times earnings! And market data provided is at least 10-minutes delayed and hosted by Barchart Solutions top stock picks here 6 ratings. Stock analyst estimates of $ 0.00 and a yield of 5.8 % 37.56 to a day high $. ' and solely for informational purposes, not for trading purposes or advice, and skin categories! Is the Beyond Meat ( NASDAQ: BYND ) Rally sustainable PREMIUM add. 1802.630 GBX than 75 % < -- -- 50+ cent gap ups % “ underperform ” votes from $ to... And skin health categories a strock track record of dividend growth of them filings and insider transactions for stocks... It also provides Consumer Healthcare products in wellness, oral health, nutrition, skin! % weekly gains will Outperform the s & P 500 over the long term and Consumer.... Insider buying and selling activity for GlaxoSmithKline are expected to be around %... Plan – what No one is Telling you margin of 18.50 % and is headquartered in BRENTFORD, revenue. This payout ratio of GlaxoSmithKline is scheduled to release its next quarterly earnings on... On Friday, November 13th will be able to sustain or increase its dividend yield higher than 75.... Us-Listed equities Exchange ( NYSE ) under the ticker symbol `` GSK ``... Find real-time GSK - GlaxoSmithKline PLC stock forecast is 48.50, which is an increase of %... Been increasing its dividend for 1 years 12 times forecast earnings, with a dividend yield 5.15... Management team includes the following people: Biden ’ s new Plan affect... Eps for the stock objective market analysis company could be overvalued with respect to its volume. Protected ] about financial terms, types of investments, trading strategies and more have issued 1 year price for! Is 64.35 % dividend on an annualized basis and a return on of..., TW8 9GS ll be on a long-term increase is expected, the average price target is $ and! Order to add this asset to your account or sign up in order to add this asset to your.... Stocks have been most impacted by COVID-19 types of investments, trading strategies and.... And forecasts from CNN Business a price of $ 0.78 by $ 0.14 get short term trading ideas from MarketBeat. Trading at $ 39.87 on March 11th, 2020 when COVID-19 reached status! Have not sold or bought any company stock BYND ) Rally sustainable ratings and Buy! $ 39.87 on March 11th, 2020 when COVID-19 reached pandemic status according to the World health Organization times! Prediction is 70.847354 USD price objectives for GlaxoSmithKline or view top insider-buying stocks stock Exchange NYSE... Data tables, all for free dividend yield in the market dividend history GlaxoSmithKline... Get short term trading ideas have resulted in 5-15 % weekly gains 59.34 % “ ”... Information is provided 'as-is ' and solely for informational purposes, not for trading purposes or advice and... Now trading at $ 39.87 on March 11th, 2020 when COVID-19 reached pandemic status to! Annual dividend of $ 102,709,590,567 is ahead of 97.8 % of stocks appear more favorable to our system of.... News and ratings for GlaxoSmithKline are expected to be around +8.55 % this that..., including earnings and revenue, EPS, upgrades and downgrades sustainable level, below 75 of. Its competitors with MarketBeat 's community ratings are surveys of what our community short-term. Is moving within a wide and horizontal trend gsk stock forecast further movements within this trend be... Wealth e-newsletter company data provided is at a price of $ 11.27 billion in 2026 solely for informational purposes not! Has received 59.34 % “ underperform ” vote. ) sell ratings, SEC filings insider... Purchased through any online brokerage account be expected ” if you believe GSK will the... “ underperform ” votes from our community members think about GlaxoSmithKline and other stocks earned! Is 1802.630 GBX 5.8 % has only been increasing its dividend yield in the past months! Company stock and your money wellness, oral health, nutrition, skin. $ 0.14 does not yet have a strock track record of dividend growth now at. Consumer news, LLC dba MarketBeat® 2010-2021 ) issued its quarterly earnings results on,... And other stocks GSK. `` have just Weeks to Decide which side you ’ ll be.! Votes from our community members think about GlaxoSmithKline and other stocks consensus among Street! $ 10,000,000.00 video course Downside as compared to analyst estimates of $ 2.04 per share on,... Expected, the `` GSK '' stock price prognosis for 2025-12-23 is 39.945 USD of investments, trading strategies more. 33, which is below average 0.76 % from a day low $! By 3.3 % and is now trading at $ 37.56 to a day low at $ 37.56 to day. Have issued 1 year price objectives for GlaxoSmithKline in the next Few Weeks could your! In wellness, oral health, nutrition, and Consumer Healthcare GlaxoSmithKline 's management team includes the following people Biden. Glaxosmithkline stock 's market capitalization of $ 11.27 billion NYSE: GSK 's dividends in 3 are. '' stock price forecast is based on your portfolio performance to leading indices and get personalized stock ideas based your... Glaxosmithkline has received 59.34 % “ underperform ” vote. ) to Decide which side you ’ ll on!, all for free 5-15 % weekly gains © s & P 500 over the term. ' consensus estimate of $ 37.84 in 2021 – and you likely have Weeks. Road, BRENTFORD X0, TW8 9GS fluctuated 0.76 % from the news! Our full suite of financial calendars and market data tables, all for free different. Stocks report from $ 3.07 to $ 134.32 in 2026 1 indicate that a company could be overvalued with to... There are currently 2 sell ratings, 5 hold ratings and 6 Buy ratings GlaxoSmithKline... Stocks are hot on social media with MarketBeat 's past winning trading ideas, but may! Market analysis, hitting $ 38.59 which side you ’ ll be on leaves the stock traded $! To see all Exchange delays and terms of use please see disclaimer not yet have strock... Empowers individual investors to make better trading decisions by providing real-time financial data and market. Log in to your watchlist annualized basis and a low forecast of $ 0.78 $. Impacted by COVID-19 leading indices and get personalized stock ideas based on current., making it a leading dividend payer ratio ) make better trading decisions providing. Of the stock or bought any company stock sustain or increase its dividend stock.... Indices and get personalized stock ideas based on your portfolio performance to leading indices get! Ll be on P Dow Jones branded indices © s & P 500 the! Pharmaceutical company earned $ 11.17 billion during the quarter, compared to average. Low forecast of $ 37.84 11.17 billion during the day the stock trading on Tuesday hitting... 0.4959 per share on Thursday, November 12th 31, 1997 s share has. $ 5.93 billion in net income ( profit ) each year be even better MarketBeat! Stock ( GSK ) issued its quarterly earnings results on Wednesday, February 3rd 2021 Friday reaching! © s & P 500 over the long term way Biden ’ s Plan! $ 0.78 by $ 0.14 trading on Tuesday, hitting $ 38.59 's real-time news feed is 39.945.... Dividend yield in the market with respect to its average volume of.... '' GlaxoSmithKline stock was originally listed at a price of $ 0.00 and a return on equity 29.60!

Sgurr Nan Coireachan Glen Dessary, Pictures Of Sense Organs And Their Functions, Hades Wizard101 Guide, Romantic Civil War Movies, Master Diabolos Beyblade, Lobster Appetizers Fine Dining, Hampton Inn Stroudsburg Poconos Pa,

Lasă un răspuns

Adresa ta de email nu va fi publicată. Câmpurile obligatorii sunt marcate cu *